Revision of CureVac

{{DISPLAYTITLE:CureVac}}[[File:Curevac in T%C3%BCbingen 02.jpg|frameless|right]]
CureVac N.V. is a German biopharmaceutical company, legally domiciled in the Netherlands and headquartered in Tübingen, Germany, that develops therapies based on messenger RNA (mRNA).<small> from [https://en.wikipedia.org/wiki/CureVac Wikipedia]</small>
{|
|+ 
|-
! Icon !! Service !! Username !!
{{DISPLAYTITLE:CureVac}}[[File:Curevac in Tübingen 02.jpg|frameless|right]]
CureVac N.V. is a German biopharmaceutical company that develops therapies based on messenger RNA (mRNA). Legally domiciled in the Netherlands and headquartered in Tübingen, Germany, the company was founded in 2000 by Ingmar Hoerr (CEO), Steve Pascolo (CSO), Florian von der Mulbe (COO), Günther Jung, and Hans-Georg Rammensee.<small> from [https://en.wikipedia.org/wiki/CureVac Wikipedia]</small>

{{SF|
{{Twt|CureVacAG}}
{{Wb|https://www.curevac.com/|https:www.curevac.com}}
{{Wb|https://www.curevac.com/|curevac.com}}
{{Fb|CureVac}}
{{Yt|UCtwge2rdqHr50rxnf45ltcw|CureVac}}
|}
}}
{{IDF|
{{Wd|Q1144473}}
{{Isni|0000000453454022}}
}}
{{VIAF|264796105}}

[[VHID]]:[https://verifiedhandles.com/vhid/17465622300 17465622300]
{{#subtitle: <big>biopharmaceutical company in Germany</big>}}
{{VHID|17465622300}}{{#subtitle: <big>biopharmaceutical company in Germany</big>}}